Collateral for a security interest recorded Jun 13, 2025 (JPMorgan Chase Bank, N.A.).
Term ended Oct 30, 2026 · High confidence
Held by Solta Medical, Inc.
Filed May 20, 2010 as application 29/362,163 · Granted Oct 30, 2012
Base term, 14 years from grant
Today
Term ended Oct 30, 2026
2012
2026
Clock starts
Oct 30, 2012
Oct 30, 2012
Term ended
Oct 30, 2026
Oct 30, 2026
base term
after the term ends
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
14 years from grant
Base term
No maintenance fees are payable on this kind of patent.
This patent's term is its base term, 14 years from grant, with no adjustment for prosecution delay. No maintenance fees are payable on this kind of patent. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 14 years from grant | Granted Oct 30, 2012 | Oct 30, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Computed term end | The steps above, in order | Oct 30, 2026 | High confidence |
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 2, 2010 Reel 25439, frame 870 | Schafer, Mark E.; Merchant, Adnan I.; Matteson, Kristen E.; Chase, Serena Ann; Wesley, David J.; Mogil, David B.; Joseph, Arjun K.; Massam, Daniel J.; Lynch, Kailyn N. | Sound Surgical Technologies LLC | Assignment of Assignor's Interest |
| May 2, 2011 Reel 26210, frame 237 | Sound Surgical Technologies LLC | Silicon Valley Bank | Security Agreement |
| Nov 19, 2013 Reel 31674, frame 568 | Sound Surgical Technologies, LLC | Capital Royalty Partners II L.P.; Capital Royalty Partners II - Parallel Fund "a" L.P.; Parallel Investment Opportunities Partners II L.P. | Short-Form Patent Security Agreement |
| Nov 19, 2013 reel/frame not recorded | Sound Surgical Technologies, LLC | Capital Royalty Partners II L.P. | Short-Form Patent Security Agreement |
| Nov 19, 2013 reel/frame not recorded | Sound Surgical Technologies, LLC | Capital Royalty Partners II - Parallel Fund "a" L.P. | Short-Form Patent Security Agreement |
| Nov 19, 2013 reel/frame not recorded | Sound Surgical Technologies, LLC | Parallel Investment Opportunities Partners II L.P. | Short-Form Patent Security Agreement |
| Jan 27, 2014 Reel 32127, frame 129 | Capital Royalty Partners II L.P.; Capital Royalty Partners II - Parallel Fund "a" L.P.; Parallel Investment Opportunities Partners II L.P. | Sound Surgical Technologies LLC | Release of Security Interest in Patents |
| Jan 27, 2014 Reel 32127, frame 587 | Silicon Valley Bank | Sound Surgical Technologies LLC | Release of Security Interest in Patents |
| Mar 11, 2019 Reel 48556, frame 758 | Bausch Health Americas, Inc.; Bausch & Lomb Incorporated; Bausch Health US, LLC; Solta Medical, Inc.; Medicis Pharmaceutical Corporation; Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Orapharma, Inc.; Precision Dermatology, Inc. | The Bank of New York Mellon, as Notes Collateral Agent | Security Interest |
| May 12, 2021 Reel 56214, frame 690 | Sound Surgical Technologies LLC | Solta Medical, Inc. | Merger |
| Jun 8, 2021 Reel 56811, frame 814 | Bausch & Lomb Incorporated; Bausch Health US, LLC; Solta Medical, Inc.; Medicis Pharmaceutical Corporation; Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Orapharma, Inc.; Precision Dermatology, Inc.; Bausch Health Americas, Inc. | The Bank of New York Mellon, as Notes Collateral Agent | Security Interest |
| Feb 10, 2022 Reel 59121, frame 1 | Bausch & Lomb Incorporated; Bausch Health US, LLC; Solta Medical, Inc.; Medicis Pharmaceutical Corporation; Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Orapharma, Inc.; Precision Dermatology, Inc.; Bausch Health Americas, Inc. | The Bank of New York Mellon | Security Agreement |
| Jun 13, 2022 Reel 60346, frame 705 | Bausch Health Companies Inc.; Bausch Health, Canada Inc.; Bausch Health Ireland Limited; Solta Medical Ireland Limited | The Bank of New York Mellon | Security Interest |
| Oct 4, 2022 Reel 61595, frame 66 | Bausch Health US, LLC; Bausch Health Americas, Inc.; Medicis Pharmaceutical Corporation; Orapharma, Inc.; Precision Dermatology, Inc.; Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Solta Medical, Inc. | The Bank of New York Mellon, as Notes Collateral Agent | Security Agreement (First Lien) |
| Oct 5, 2022 Reel 61606, frame 468 | Bausch Health US, LLC; Bausch Health Americas, Inc.; Medicis Pharmaceutical Corporation; Orapharma, Inc.; Precision Dermatology, Inc.; Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Solta Medical, Inc. | The Bank of New York Mellon, as Notes Collateral Agent | Security Agreement (Second Lien) |
| Jun 13, 2025 Reel 71564, frame 463 | Medicis Pharmaceutical Corporation; Orapharma, Inc.; Bausch Health US, LLC (F/K/A Valeant Pharmaceuticals North America LLC); Precision Dermatology, Inc.; Salix Pharmaceuticals, Inc.; Santarus, Inc.; Bausch Health Americas, Inc.; Solta Medical, Inc. | The Bank of New York Mellon | U.S. Patent Security Agreement |
| Jun 13, 2025 Reel 71566, frame 200 | Medicis Pharmaceutical Corporation; Orapharma, Inc.; Bausch Health US, LLC (F/K/A Valeant Pharmaceuticals North America LLC); Precision Dermatology, Inc.; Salix Pharmaceuticals, Inc.; Santarus, Inc.; Bausch Health Americas, Inc.; Solta Medical, Inc. | Jpmorgan Chase Bank, N.a. | U.S. Patent Security Agreement |
| Nov 20, 2025 Reel 73654, frame 242 | The Bank of New York Mellon, as Notes Collateral Agent | Bausch & Lomb Incorporated; Bausch Health US, LLC; Solta Medical, Inc.; Medicis Pharmaceutical Corporation; Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Orapharma, Inc.; Precision Dermatology, Inc.; Bausch Health Americas, Inc. | Release of Security Interest |
| Nov 20, 2025 Reel 73654, frame 300 | The Bank of New York Mellon, as Notes Collateral Agent | Bausch Health Companies Inc.; Bausch Health, Canada Inc.; Bausch Health Ireland Limited; Solta Medical Ireland Limited | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Bausch Health Americas, Inc. | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Bausch & Lomb Incorporated | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Bausch Health US, LLC | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Solta Medical, Inc. | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Medicis Pharmaceutical Corporation | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Salix Pharmaceuticals, Inc. | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Salix Pharmaceuticals, Ltd. | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Santarus, Inc. | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Orapharma, Inc. | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Precision Dermatology, Inc. | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Bausch Health Companies Inc. | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Bausch Health, Canada Inc. | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Bausch Health Ireland Limited | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Solta Medical Ireland Limited | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center
No maintenance fees are payable on this kind of patent, so the record carries no fee events.
Citations
306
later US patents cite this one
That is top 1% of design patents granted in 2012 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.